First Time Loading...
A

Anagenics Ltd
ASX:AN1

Watchlist Manager
Anagenics Ltd
ASX:AN1
Watchlist
Price: 0.009 AUD -10% Market Closed
Updated: Apr 27, 2024

Intrinsic Value

AN1 doesn't have a meaningful market cap.

Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases o... [ Read More ]

The intrinsic value of one AN1 stock under the Base Case scenario is 0.019 AUD. Compared to the current market price of 0.009 AUD, Anagenics Ltd is Undervalued by 53%.

Key Points:
AN1 Intrinsic Value
Base Case
0.019 AUD
Undervaluation 53%
Intrinsic Value
Price
A
Base Case Scenario

Valuation Backtest
Anagenics Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AN1 stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Anagenics Ltd

Provide an overview of the primary business activities
of Anagenics Ltd.

What unique competitive advantages
does Anagenics Ltd hold over its rivals?

What risks and challenges
does Anagenics Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Anagenics Ltd.

Provide P/S
for Anagenics Ltd.

Provide P/E
for Anagenics Ltd.

Provide P/OCF
for Anagenics Ltd.

Provide P/FCFE
for Anagenics Ltd.

Provide P/B
for Anagenics Ltd.

Provide EV/S
for Anagenics Ltd.

Provide EV/GP
for Anagenics Ltd.

Provide EV/EBITDA
for Anagenics Ltd.

Provide EV/EBIT
for Anagenics Ltd.

Provide EV/OCF
for Anagenics Ltd.

Provide EV/FCFF
for Anagenics Ltd.

Provide EV/IC
for Anagenics Ltd.

What are the Revenue projections
for Anagenics Ltd?

How accurate were the past Revenue estimates
for Anagenics Ltd?

What are the Net Income projections
for Anagenics Ltd?

How accurate were the past Net Income estimates
for Anagenics Ltd?

What are the EPS projections
for Anagenics Ltd?

How accurate were the past EPS estimates
for Anagenics Ltd?

What are the EBIT projections
for Anagenics Ltd?

How accurate were the past EBIT estimates
for Anagenics Ltd?

Compare the revenue forecasts
for Anagenics Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Anagenics Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Anagenics Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Anagenics Ltd compared to its peers.

Compare the P/E ratios
of Anagenics Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Anagenics Ltd with its peers.

Analyze the financial leverage
of Anagenics Ltd compared to its main competitors.

Show all profitability ratios
for Anagenics Ltd.

Provide ROE
for Anagenics Ltd.

Provide ROA
for Anagenics Ltd.

Provide ROIC
for Anagenics Ltd.

Provide ROCE
for Anagenics Ltd.

Provide Gross Margin
for Anagenics Ltd.

Provide Operating Margin
for Anagenics Ltd.

Provide Net Margin
for Anagenics Ltd.

Provide FCF Margin
for Anagenics Ltd.

Show all solvency ratios
for Anagenics Ltd.

Provide D/E Ratio
for Anagenics Ltd.

Provide D/A Ratio
for Anagenics Ltd.

Provide Interest Coverage Ratio
for Anagenics Ltd.

Provide Altman Z-Score Ratio
for Anagenics Ltd.

Provide Quick Ratio
for Anagenics Ltd.

Provide Current Ratio
for Anagenics Ltd.

Provide Cash Ratio
for Anagenics Ltd.

What is the historical Revenue growth
over the last 5 years for Anagenics Ltd?

What is the historical Net Income growth
over the last 5 years for Anagenics Ltd?

What is the current Free Cash Flow
of Anagenics Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Anagenics Ltd.

Financials

Balance Sheet Decomposition
Anagenics Ltd

Current Assets 5.4m
Cash & Short-Term Investments 1.3m
Receivables 709k
Other Current Assets 3.4m
Non-Current Assets 5.9m
PP&E 1.2m
Intangibles 4.7m
Current Liabilities 3.8m
Accounts Payable 2.7m
Accrued Liabilities 181.7k
Other Current Liabilities 930.3k
Non-Current Liabilities 381.3k
Long-Term Debt 341.6k
Other Non-Current Liabilities 39.8k
Efficiency

Earnings Waterfall
Anagenics Ltd

Revenue
10.2m AUD
Cost of Revenue
-5.4m AUD
Gross Profit
4.7m AUD
Operating Expenses
-7.3m AUD
Operating Income
-2.5m AUD
Other Expenses
-643.8k AUD
Net Income
-3.2m AUD

Free Cash Flow Analysis
Anagenics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

AN1 Profitability Score
Profitability Due Diligence

Anagenics Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Positive 3-Years Revenue Growth
29/100
Profitability
Score

Anagenics Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

AN1 Solvency Score
Solvency Due Diligence

Anagenics Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
58/100
Solvency
Score

Anagenics Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AN1 Price Targets Summary
Anagenics Ltd

There are no price targets for AN1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

AN1 Price
Anagenics Ltd

1M 1M
-25%
6M 6M
-63%
1Y 1Y
-57%
3Y 3Y
-86%
5Y 5Y
-95%
10Y 10Y
-98%
Annual Price Range
0.009
52w Low
0.009
52w High
0.026
Price Metrics
Average Annual Return -35.09%
Standard Deviation of Annual Returns 30.44%
Max Drawdown -97%
Shares Statistics
Market Capitalization 3.8m AUD
Shares Outstanding 419 132 992
Percentage of Shares Shorted
N/A

AN1 Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Anagenics Ltd

Country

Australia

Industry

Consumer products

Market Cap

3.8m AUD

Dividend Yield

0%

Description

Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The principal activities of the Company include the development, distribution and sale of health, beauty and wellness products (Consumer health). The firm through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures, markets, distributes to retailers, and sells its anti-aging products globally, with its FGF5 inhibitor, hair health and hair growth products. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju, and Lexilis brands are sold in Australia, Japan, and the United States of America. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of premium Australian and international beauty and wellness brands, primarily to salons and spas.

Contact

NEW SOUTH WALES
Sydney
Suite 204, Level 2, 55 Clarence Street
+61292216830.0
https://anagenics.com/

IPO

2005-12-09

Employees

-

Officers

CEO & Director
Ms. Karen Matthews
Chief Financial & Governance Officer and Company Secretary
Mr. Matthew Dudek
Executive Director
Mr. Scott Mitchell Greasley
Chief Operating Officer
Mr. Dominic Burg
Head of Research & Development
Dr. Graham Robertson

See Also

Discover More
What is the Intrinsic Value of one AN1 stock?

The intrinsic value of one AN1 stock under the Base Case scenario is 0.019 AUD.

Is AN1 stock undervalued or overvalued?

Compared to the current market price of 0.009 AUD, Anagenics Ltd is Undervalued by 53%.